Status:
COMPLETED
Endothelial Cell Loss After Penetrating Keratoplasty
Lead Sponsor:
Alexandria University
Conditions:
Keratoconus
Eligibility:
All Genders
18-80 years
Phase:
PHASE2
PHASE3
Brief Summary
This work aimed at the assessment of corneal endothelial cell loss after toric ICL implantation for correction of myopia and astigmatism after penetrating keratoplasty.
Detailed Description
Penetrating keratoplasty (PKP) is considered a safe and effective procedure.This work aimed at the assessment of corneal endothelial cell loss after toric ICL implantation for correction of myopia and...
Eligibility Criteria
Inclusion
- PKP for keratoconus, and then toric ICL was implanted after minimum of one year with stable refraction
Exclusion
- Less than 18 and unable to give informed consent
Key Trial Info
Start Date :
July 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 15 2020
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT04457063
Start Date
July 1 2018
End Date
June 15 2020
Last Update
July 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alexandria Faculty of Medicine
Alexandria, Egypt